Table 2.
Factors involved in coupling type H vessel formation and osteogenesis.
| Factors | Property | Main source/location | Effect on type H vessel | Coupling effect on osteogenesis | Reference |
|---|---|---|---|---|---|
| PDGF-BB | Growth factor | Macrophage/non-resorbing osteoclast lineage cells | Induce type H vessel formation during bone modeling and remodeling | Promote the migration and differentiation of MSCs and endothelial progenitor cells; Stimulate bone formation in the ovariectomy induced osteoporotic mouse model |
[340] |
| Macrophage-lineage TRAP+ cells | Recruit periosteum-derived cells to the periosteal surface and direct its differentiation which contribute to cortical bone formation | [341] | |||
| VEGF-A | Growth factor | Chondrocytes; Osteoclasts; Osteoblasts | Promote type H vessel formation; However, persistent VEGFA signaling can impair PDGF-BB effects on pericytes leading to leaky blood vessels | Couple angiogenesis to enhance osteogenesis; Direct the differentiation of MSCs into osteoblast; However, high concentration of VEGF recruit osteoclast resulting in bone loss |
[[342], [343], [344], [345]] |
| SLIT3 | SLIT ligand (protein) | Osteoblast | Promote type H vessel formation | Mediate osteogenesis by regulating production of type H vessel | [346] |
| Osteoclast | Promote osteoblast migration and proliferation via activating β-catenin; Suppress osteoclast differentiation and bone resorption in an autocrine manner |
[347] | |||
| HIF-1α | Transcription factor | Osteoprogenitors; Osteoblast; Endothelial cell |
Activation of HIF-1α signaling in ECs led to an increased formation of type H vessels | Activation of HIF-1α promote the formation of trabecular bone and increase the numbers of Runx2+ and Osterix+ osteoprogenitors; The expression of HIF-1α in ECs decreases with age, accompanied by a decrease in type H vessels and bone mass; Promote bone regeneration in a VEGF dependent manner |
[335,348] |
| Notch (Delta-like 4) | Receptor (ligand) | Endothelial cell | Promote type H vessel formation and EC Noggin (Notch signaling activator) secretion | Promote proliferation and inhibit differentiation of mesenchymal progenitors; Promote proliferation and differentiation of osteoblasts; Activation of endothelial-cell-specific Notch signaling increase Runx2+ osteoprogenitors and osteoblastic differentiation, as well as promote chondrocyte maturation, bone growth and the formation of trabeculae |
[335,342,349,350] |